RecruitingNCT07182981

Patients Diagnosed With Scleroderma and Their Chewing and Swallowing Performance

Investigating the Relationship Between the Biopsychosocial Status of Patients Diagnosed With Scleroderma and Their Chewing and Swallowing Performance


Sponsor

Hacettepe University

Enrollment

50 participants

Start Date

Aug 4, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

It is recommended to focus on the physical functionality, chewing, and swallowing performance of individuals diagnosed with scleroderma. There is a need to address children and adults diagnosed with scleroderma comprehensively and to evaluate them on a biopsychosocial basis to support their disease management. The aim was to assess the biopsychosocial characteristics of both children and adults diagnosed with scleroderma and to examine their chewing and swallowing performance. Additionally, this study aims to identify effective scales that can be used in future research to assess chewing and swallowing in individuals diagnosed with scleroderma.


Eligibility

Min Age: 7 Years

Inclusion Criteria5

  • For a child diagnosed with scleroderma:
  • Cases diagnosed with scleroderma,
  • Cases aged 7-18 years will be included.
  • Individuals diagnosed with scleroderma,
  • Individuals over the age of 18 will be included.

Exclusion Criteria9

  • Advanced heart/lung/liver/kidney disease, neurological disease, and malignancies
  • Cases that are not willing to participate in the study will be excluded.
  • Having participated in a regular exercise program for the past 3 months
  • Individuals who are not willing to participate in the study
  • For adults diagnosed with scleroderma:
  • Advanced heart/lung/liver/kidney disease, neurological disease, and malignancies
  • Individuals who are not willing to participate in the study will be excluded.
  • Having participated in a regular exercise program for the past 3 months
  • Individuals who are not willing to participate in the study

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERQuestionnaire application for child and adult scleroderma patients

Scales will be applied to cases diagnosed with scleroderma


Locations(1)

Hacettepe University

Çankaya, Ankara, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07182981


Related Trials